124 related articles for article (PubMed ID: 14619474)
1. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis].
Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1602-4. PubMed ID: 14619474
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis].
Maruyama M; Nagahama T; Ebuchi M; Yuasa Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1855-7. PubMed ID: 11086429
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis.
Maruyama M; Nagahama T; Yuasa Y
Anticancer Res; 1999; 19(5B):4187-91. PubMed ID: 10628373
[TBL] [Abstract][Full Text] [Related]
4. [Experimental study on intraperitoneal and intravenous administration of anti-tumor agents for liver metastasis].
Maruyama M; Nagahama T; Ebuchi M; Irie T; Yoshida T; Kure M
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1782-5. PubMed ID: 10560394
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic study of the intraperitoneal administration of CPT-11 for patients with peritoneal seedings of gastric and colonic cancers].
Maruyama M; Toukairin Y; Baba H; Kure N; Nagahama T; Ebuchi M
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1505-7. PubMed ID: 11707965
[TBL] [Abstract][Full Text] [Related]
6. [Liver concentration of CPT-11, SN-38 and SN-38 GLU in intraperitoneal and intravenous administration of CPT-11].
Maruyama M; Nagahama T; Yuasa Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1967-9. PubMed ID: 10560438
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model.
Hribaschek A; Kuhn R; Pross M; Meyer F; Fahlke J; Ridwelski K; Boltze C; Lippert H
Surg Today; 2006; 36(1):57-62. PubMed ID: 16378195
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study.
Li PC; Chen LD; Zheng F; Li Y
J Cancer Res Clin Oncol; 2008 Jan; 134(1):37-44. PubMed ID: 17665213
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis.
Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H
Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study on intraperitoneal sequential MTX/5-FU therapy for peritoneal seeding in comparison with intravenous administration].
Maruyama M; Takamatsu S; Sugano N; Ebuchi M; Endo M; Yuasa Y
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2131-6. PubMed ID: 9388524
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study on intraperitoneal administration of 5-fluorouracil for liver metastasis in comparison with intravenous administration].
Maruyama M; Sugano N; Ebuchi M; Yuasa Y
Gan To Kagaku Ryoho; 1999 Mar; 26(4):497-502. PubMed ID: 10097746
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
Ohashi N; Kodera Y; Nakanishi H; Yokoyama H; Fujiwara M; Koike M; Hibi K; Nakao A; Tatematsu M
Int J Oncol; 2005 Sep; 27(3):637-44. PubMed ID: 16077911
[TBL] [Abstract][Full Text] [Related]
13. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice.
Guichard S; Chatelut E; Lochon I; Bugat R; Mahjoubi M; Canal P
Cancer Chemother Pharmacol; 1998; 42(2):165-70. PubMed ID: 9654118
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice.
Shimada T; Nomura M; Yokogawa K; Endo Y; Sasaki T; Miyamoto K; Yonemura Y
J Pharm Pharmacol; 2005 Feb; 57(2):177-81. PubMed ID: 15720780
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases.
Archer S; Gray B
Surgery; 1990 Sep; 108(3):502-7. PubMed ID: 2396194
[TBL] [Abstract][Full Text] [Related]
18. [A case of peritoneal dissemination disappeared by CPT-11 + TS-1 combination chemotherapy].
Takemoto H; Fukunaga M; Ooshiro R; Fujishima M; Yamamoto K; Tanaka J; Kondo M; Kishimoto T; Nakayama T; Imamura H; Masutani S; Tatsuta M; Kawasaki T; Furukawa H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1768-70. PubMed ID: 16315935
[TBL] [Abstract][Full Text] [Related]
19. [A case of gastric cancer with peritoneal dissemination which shows a remarkable efficacy by a weekly administration of paclitaxel intraperitoneally].
Kato K; Koide A; Oobu M; Hasegawa K; Maruyama S; Takashima I; Nagahama T; Maruyama M; Ebuchi M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1852-4. PubMed ID: 15553737
[TBL] [Abstract][Full Text] [Related]
20. [Effect of administration schedules on the antitumor activity of CPT-11, a camptothecin derivative].
Furuta T; Yokokura T
Gan To Kagaku Ryoho; 1990 Jan; 17(1):121-30. PubMed ID: 2297233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
